Skip to content
Screener

Bausch + Lomb BLCO Q1 2026 earnings

Reported April 29, 2026 · Before market open

Revenue$1.2BBeat by $28.3M
EPS$0.08Beat by $0.02
Revenue estimate$1.2B
EPS estimate$0.06

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$1.4B
EPS estimate$0.21

Financials

Q1 2026

Income statement

See full
Revenue$1.2B+9.4%
Operating income$33.0M+140%
Net income-$71.0M+66.5%
EPS (diluted)-$0.20+66.7%

Balance sheet

See full
Cash & equivalents$279.0M+29.8%
Total debt$5.0B+4.3%
Total equity$6.4B+0.3%
Total assets$13.8B+2.6%

Cash flow

See full
Operating cash flow$32.0M+228%
CapEx$100.0M-9.1%
Free cash flow-$68.0M+49.6%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$5.63B+10.2%
Enterprise value$10.39B+6.9%
P/S1.1×0.0×

Profitability

See full
Operating margin4.4%+2.9pp
Net margin-4.2%-1.3pp

Returns & leverage

See full
Return on equity-3.4%-0.9pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Segments

By segment

See full
Vision Care$711.0M+8.4%
Pharmaceuticals$266.0M+19.8%
Surgical$228.0M+6.5%

By product

See full
Devices$480.0M+7.1%
OTC$444.0M+8.6%
Branded and Other Generics$49.0M-9.3%

FAQ

When did Bausch + Lomb report Q1 2026 earnings?
Bausch + Lomb (BLCO) reported Q1 2026 earnings on April 29, 2026 before market open.
What were Bausch + Lomb's Q1 2026 revenue and EPS?
Bausch + Lomb reported revenue of $1.2B and eps of $0.08 for Q1 2026.
Did Bausch + Lomb beat estimates in Q1 2026?
Revenue beat the consensus estimate of $1.2B by $28.3M. EPS beat the consensus estimate of $0.06 by $0.02.
How did Bausch + Lomb's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.8% from $1.1B a year earlier.
Where can I find Bausch + Lomb's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001860742-26-000060) and the 10-Q periodic report (0001860742-26-000062) directly on SEC EDGAR. The filing index links above go to sec.gov.